Deep Track Capital
Tracked across 2 events · 13 articles · First seen Apr 14, 2026 · Last active Aug 19, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Fulcrum Therapeutics and Slate Medicines have signed a definitive all-stock merger agreement to create a combined company focused on next-generation migraine treatments. The combined entity will operate as Slate Medicines and trade on Nasdaq under…
Impact: Deep Track Capital participated in the private placement financing.
Aug 17, 2026 · 6 articles
Business
Impact: Deep Track Capital is a current Obsidian Therapeutics, Inc. investor participating in the private placement financing.
Apr 14, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Deep Track Capital live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard